B O O K - American College of Rheumatology

ACR/ARHP Poster Session B
1294. Endothelin-1 (ET-1) Induces Collagen Type I and Type III
Production by Temporal Artery-Derived Myointimal Cells.
A Mechanism Potentially Leading to Intimal Hyperplasia in
Giant-Cell Arteritis (GCA). Ester Planas-Rigol, Marc Corbera-
Bellalta, Ester Lozano, Montserrat Butjosa, Sergio Prieto-
González, José Hernández-Rodríguez, Marta Segarra and Maria
C. Cid, Department of Systemic Autoimmune Diseases. Hospital
Clínic. University of Barcelona, IDIBAPS, Barcelona, Spain.
1295. Expansion of Peripheral Blood Plasma Blasts Reflects
Disturbances of B Cell Homeostasis in Patients with Takayasu
Arteritis and Success of B Cell Depletion Therapy. Bimba F.
Hoyer 3 , Imtiaz M. Mumtaz 3 , Udo Schneider 2 , Rolf Keitzer 1 , Gerd-
Rüdiger Burmester 2 , Andreas Radbruch 5 and Falk Hiepe 4 , 1 Dep.
Pediatric Rheumatology, Charité Universityhospital Berlin, 2 Dep.
Rheumatology and Clin. Immunology, Charité Universityhospital
Berlin, 3 Dep. Rheumatology and Clin. Immunology, Charité
Universityhospital Berlin and German Rheumatism Reserach
Center Berlin, Berlin, Germany, 4 Dep. Rheumatology and Clin.
Immunology, Charité Universityhospital Berlin and German
Rheumatism Reserach Center Berlin, 5 German Rheumatism
Reserach Center Berlin.
1296. Expression and Function of Toll Like Receptors in Peripheral
Blood Mononuclear Cells of Patients with Polymyalgia
Rheumatica and Giant Cell Arteritis. Lorena Alvarez-Rodriguez 4 ,
Marcos Lopez-Hoyos 4 , Cristina Mata 1 , Ana Fontalba 4 , Jaime
Calvo-Alen 1 , Maria Jose Marin 4 , Jose Luis Fernandez-Luna 4 , Jesus
Agüero-Balbin 4 , Maitane Aranzamendi-Zaldunbide 4 , Ricardo
Blanco 4 , Ignacio Villa 2 , Orlando Pompei 4 , Marien Peiro 4 , Teresa
Ruiz 1 and Victor M. Martinez-Taboada 3 , 1 Hospital de Sierrallana,
Spain, 2 Hospital de Sierrallana, 3 Hospital Universitario Marques
de Valdecilla, Santander, Spain, 4 Hospital Universitario Marques
de Valdecilla.
1297. Extracellular HMGB1 Is Increased in Patients with Behcet’s
Disease with Intestinal Involvement. Joong Kyong Ahn 2 ,
You Sun Lee 3 , Eun-Jung Park 4 , Ji-Won Hwang 4 , Ji-Min Oh 4 ,
Jaejoon Lee 4 , Chan-Hong Jeon 1 , Eun-Mi Koh 4 and Hoon-Suk
Cha 4 , 1 Bucheon Hospital, Soonchunhyang University College
of Medicine, 2 Kangbuk Samsung Hospital, Sungkyunkwan
University School of Medicine, 3 Masan Samsung Hospital,
Sungkyunkwan University School of Medicine, 4 Samsung
Medical Center, Sungkyunkwan University School of Medicine.
1298. Eye Involvement in Behcet’s Syndrome Patients in a North
American Cohort. Johannes Nowatzky 3 , Maria T. Filopoulos 4 ,
Christopher Swearingen 1 and Yusuf Yazici 2 , 1 Biostatistics UAMS
Pediatrics, 2 Hospital for Joint Diseases, Hastings on Hudson, NY,
3
NYU Hospital for Joint Diseases, Brooklyn, NY, 4 NYU Hospital for
Joint Diseases.
1299. Glucocorticoid Therapy in Giant Cell Arteritis: Duration and
Predictors for Long-Lasting Remission. Paula Estrada, Javier
Narvaez, Laura Lopez Vives, Carmen Gomez Vaquero and
Joan Miquel Nolla, Department of Rheumatology, Hospital
Universitario de Bellvitge, Barcelona, Spain.
1300. Infliximab Therapy Is Beneficial for Intestinal Behcet’s Disease
in Japan. Reikou Watanabe, Mitsuhiro Takeno and Yoshiaki
Ishigatsubo, Department of Internal Medicine and Clinical
Immunology, Yokohama City Graduate School of Medicine.
1301. Influence of CD40 rs1883832 Polymorphism in the
Susceptibility to and Clinical Manifestations of Biopsy-
Proven Giant Cell Arteritis. Luis Rodríguez-Rodríguez 8 , Santos
Castañeda 4 , Tomás R. Vazquez-Rodriguez 7 , Inmaculada C.
Morado 3 , Beatriz Marí-Alfonso 1 , Carmen Gómez-Vaquero 5 , Jose
A. Miranda-Filloy 7 , Javier Narvaez 5 , Norberto Ortego-Centeno 2 ,
Ricardo Blanco 6 , Benjamín Fernández-Gutiérrez 3 , Javier
Martín 9 and Miguel A. Gonzalez-Gay 6 , 1 Department of Internal
Medicine, Corporació Sanitaria Parc Taulí, Instituto Universitario
Parc Taulí, UAB, Sabadell, Barcelona, Spain, 2 Department of
Internal Medicine, Hospital Clínico San Cecílio, Granada, Spain,
3
Department of Rheumatology, Hospital Clinico San Carlos,
Madrid, Spain, 4 Department of Rheumatology, Hospital de
la Princesa, Madrid, Spain, 5 Department of Rheumatology,
Hospital Universitario de Bellvitge-IDIBELL, L’Hospitalet de
Llobregat, Barcelona, Spain, 6 Department of Rheumatology,
Hospital Universitario Marqués de Valdecilla, IFIMAB, Santander,
Spain, 7 Department of Rheumatology, Hospital Xeral-Calde,
Lugo, Spain, 8 Instituto de Parasitología y Biomedicina López-
Neyra, C.S.I.C., Granada, and Department of Rheumatology,
Hospital Clinico San Carlos, Madrid, Spain, 9 Instituto de
Parasitología y Biomedicina López-Neyra, C.S.I.C., Granada,
Spain.
1302. Large-Vessel Involvement in Newly-Diagnosed Giant
Cell Arteritis: A Case-Control Study Using Color-Doppler
Sonography. Alessandra Ghinoi 1 , Luigi Boiardi 1 , Nicolò Pipitone 1 ,
Giovanna Restuccia 1 , Alberto Nicolini 1 , Mauro Silingardi 1 ,
Giuseppe Germanò 1 , Gianluigi Bajocchi 1 , Ilaria Chiarolanza 1 ,
Luca Magnani 2 , Pierluigi Macchioni 1 , Andrea Caruso 1 and Carlo
Salvarani 1 , 1 Arcispedale S Maria Nuova, Reggio Emilia, Italy,
2
Arcispedale S Maria Nuova, Reggia Emilia, Italy.
1303. New Disease Activity Indices in the Management of Behcet’s
Disease: A Comparative Study of Patients from Turkey and the
USA. Gonca Mumcu, Yusuf Yazici, Nevsun Inanc, Tulin Ergun,
Maria Filopoulos and Haner Direskeneli, Faculty of Health
Sciences, Department of Health Informatics and Technologies,
Marmara School of Medicine.
1304. Normal Sedimentation Rate and C-Reactive Protein at
Diagnosis in Biopsy-Proven Giant Cell Arteritis. Tanaz A.
Kermani, Cynthia S. Crowson, Steven R. Ytterberg, Gene G.
Hunder and Kenneth J. Warrington, Mayo Clinic, Rochester, MN.
1305. Pediatric Behçet’s Disease, PED-BD: An International Cohort
Study of 110 Patients. One-Year Follow-Up Data. Isabelle
Koné-Paut 11 , Martha Darce Bello 11 , Farahd Shahram 15 , Marco
Gattorno 7 , Rolando Cimaz 10 , Seza Ôzen 2 , Michael Hofer 14 ,
Ilknur Tugal-Tuktun 5 , Samir Assaad-Khalil 3 , Jasmin Kümmerle-
Deschner 16 , Saida Benamour 4 , Soulaymane Al Mayouf 8 ,
Christine Pajot 13 , Jordi Anton 9 , Albert Faye 12 , Susan Nielsen 6 ,
Alexia Letierce 1 and Tu-Anh Tran 11 , 1 Bicêtre University Hospital,
Clinical Research Unit, Le Kremlin-Bicêtre, France, 2 Hacettepe
University, Department of Pediatrics, Ankara, Turkey, 3 Hospital
Alexandria Hospital, Alexandria, Egypt, 4 IBN Rochid University
Hospital, Casablanca, Morocco, 5 Istanbul University -
Ophtalmology, Istambul, Turkey, 6 Pediatric Clinic, Blegdamsvej,
Copenhagen, Denmark, 7 Pediatric Rheumatology G. Gaslini
Scientific Institut, Genoa, Italy, 8 Pediatric Rheumatology King
Fayçal Hospital, Riyadh, Saudi Arabia, 9 Pediatric Rheumatology
Unit, Sant Joan de Déu University Hospital, Esplugues de
Llobregat, Spain, 10 Pediatric Rheumatology, A. Meyer Institut
Florence, Florence, Italy, 11 Pediatric Rheumatology, Bicêtre
University Hospital, Le Kremlin-Bicêtre, France, 12 Pediatric
Rheumatology, Robert Debré University Hospital, Paris, France,
13
Pediatric Rheumatology, Toulouse University Hospital,
Toulouse, France, 14 Pediatric Rheumatology, Vaudois University
Hospital, Lausanne, Switzerland, 15 Rheumatology Research
Center, Shariati Hospital, Tehran, Islamic Republic of Iran,
16
Rhumatology, Childrens Hospital, University of Tuebingen,
Tübingen, Germany.
2010 Program Book 229